The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Think that's poss but 1 bag minimum imho
Market catching on this far to cheap as this was over 25p a year ago without the FDA on the doorstep
Once aproval is given I can't see this company staying independent the valuation and money potential of the product will omjo attract a takeoutfrom a big pharma
Bargain at these levels with what is coming
Pretty much get a 2 bag on FDA approval imho back into the 20p area where is has been before.
Owl you really need to think about what your saying here more often
Atb
Should be a run to 10p this year then still only 20 odd mill market cap at 10p very cheap still
Fomo
Looks leaky RNS and it's a 2 bag minimum imho
Happy Easter all
Depends on discount if any ?
And it's still a way off from Is fine deciding at all imho
The RNS is a reality check
£173,000 (31 December 2022: £277,000).
On 1 February 2024, the Company issued 30,303,040 Ordinary Shares by way of subscription at a price of 1.65p per share, raising £0.5m before expenses. As previously announced, the Company will need to raise further funds in the coming weeks in order to strengthen its financial position and to meet its immediate working capital requirements; although there can be no guarantee of such, the directors remain confident that sufficient funding will be obtained as required. Accordingly, the financial statements have been prepared on a going concern basis, however there is material uncertainty due to the need for additional near-term funding. Please refer to the accounting policy note on going concern (Note 1 to the Financial Statements) for further information.
£173,000 (31 December 2022: £277,000).
On 1 February 2024, the Company issued 30,303,040 Ordinary Shares by way of subscription at a price of 1.65p per share, raising £0.5m before expenses. As previously announced, the Company will need to raise further funds in the coming weeks in order to strengthen its financial position and to meet its immediate working capital requirements; although there can be no guarantee of such, the directors remain confident that sufficient funding will be obtained as required. Accordingly, the financial statements have been prepared on a going concern basis, however there is material uncertainty due to the need for additional near-term funding. Please refer to the accounting policy note on going concern (Note 1 to the Financial Statements) for further information.
In the latest share talk with Zak Mir below he mentions this about getting more
Yes nice post either way holders should do well from here in
Just shows how some are under researched on value stocks.
Two other little gems I like are MTL debt free and URAH
the latter is just on verge of Emerald production and the former will be trading on a PE of one
Bonkers
Can't see it staying independent big pharma will want it imho
Yes a little Gem this one still under the radar of many should be over 10p now in a normal market
FDA opens up a lot of revenue
You allready had this issued in the RNS from the company this is just the same
Wake up
Good company good products
Could do very well from here 25p This year or more
This is normal for any mining company to say Commissioning has started good news.
If you waited until production started most would moan saying why no news on commissioning.
What do you want an up to second timeline clueless
All systems go here should get a move on over 3p next few days weeks